Cargando…
Ongoing and future COVID-19 vaccine clinical trials: challenges and opportunities
Large-scale deployment of COVID-19 vaccines will seriously affect the ongoing phases 2 and 3 randomised placebo-controlled trials assessing SARS-CoV-2 vaccine candidates. The effect will be particularly acute in high-income countries where the entire adult or older population could be vaccinated by...
Autores principales: | Dal-Ré, Rafael, Bekker, Linda-Gail, Gluud, Christian, Holm, Søren, Jha, Vivekanand, Poland, Gregory A, Rosendaal, Frits R, Schwarzer-Daum, Brigitte, Sevene, Esperança, Tinto, Halidou, Voo, Teck Chuan, Sreeharan, Nadarajah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131060/ https://www.ncbi.nlm.nih.gov/pubmed/34019801 http://dx.doi.org/10.1016/S1473-3099(21)00263-2 |
Ejemplares similares
-
Availability of oral antivirals against SARS-CoV-2 infection and the requirement for an ethical prescribing approach
por: Dal-Ré, Rafael, et al.
Publicado: (2022) -
“Let me choose my COVID-19 vaccine”
por: Dal-Ré, Rafael, et al.
Publicado: (2021) -
The need to implement non-industry COVID-19 clinical trials in non-high-income countries
por: Dal-Ré, Rafael, et al.
Publicado: (2020) -
How WHO Solidarity Plus trial participants in countries on four continents are informed in writing
por: Dal-Ré, Rafael, et al.
Publicado: (2023) -
Adaptive, platform trials assessing therapies for hospitalized COVID-19 patients: Informed consent forms omitted a few important elements of information
por: Dal-Ré, Rafael, et al.
Publicado: (2023)